Descriptive combination

COMBINATION PROFILE

Super Human Blend

Sources checked · October 16, 2026

Published for review · Scientific, medical, translation and citation review pending. Reported uses are not authorized indications. Frequency reflects mentions in supplied sources, not sales or global clinical prevalence.

Components

Community claim

Performance/recovery blend.

Community and market provenance

Community mention, not clinical evidence

    • Source: pdf04 · Page 11
    • Source: img06 · Page 1

    Evidence of the exact combination

    No controlled clinical validation of this exact marketed combination was established in this review. Ingredient evidence is not combination evidence.

    Component links are not combination evidence. A commercial name’s composition may vary.

    Uncertainty and risks

    Amino acids and NAC are not peptides; individual nutrient evidence cannot establish this product’s benefit.

    Observed in supplier/community material; prevalence not quantified.

    No dosing or mixing instructions are provided.

    Source issues and references

    References include queries and bibliographic handbook attributions; not all are clinical studies. Human review remains pending.

    1. ODS-CARNITINE

      NIH ODS: Carnitine

      October 16, 2026

    2. ODS-EXERCISE

      NIH ODS: Exercise and athletic performance

      October 16, 2026

    3. PC-ARGININE

      PubChem L-arginine (CID 6322)

      October 16, 2026

    4. PC-CITRULLINE

      PubChem L-citrulline (CID 9750)

      October 16, 2026

    5. PC-GLUTAMINE

      PubChem L-glutamine (CID 5961)

      October 16, 2026

    6. PC-L-CARNITINE

      PubChem L-carnitine (CID 10917)

      October 16, 2026

    7. PC-LYSINE

      PubChem L-lysine (CID 5962)

      October 16, 2026

    8. PC-NAC

      PubChem N-acetyl-L-cysteine (CID 12035)

      October 16, 2026

    9. PC-ORNITHINE

      PubChem L-ornithine (CID 6262)

      October 16, 2026

    10. PC-PROLINE

      PubChem L-proline (CID 145742)

      October 16, 2026

    11. PC-TAURINE

      PubChem taurine (CID 1123)

      October 16, 2026

    12. PMID16391217

      L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial.

      Schulman SP, Becker LC, Kass DA, Champion HC, Terrin ML, Forman S, Ernst KV, Kelemen MD, Townsend SN, Capriotti A, Hare JM, Gerstenblith G.

      October 16, 2026

    13. PMID20386132

      Citrulline malate enhances athletic anaerobic performance and relieves muscle soreness

      October 16, 2026

    14. PMID23594003

      A randomized trial of glutamine and antioxidants in critically ill patients.

      Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, Elke G, Berger MM, Day AG, Canadian Critical Care Trials Group.

      October 16, 2026

    15. PMID29969301

      A randomized, double-blind and placebo-controlled crossover trial on the effect of l-ornithine ingestion on the human circadian clock.

      Fukuda T, Haraguchi A, Takahashi M, Nakaoka T, Fukazawa M, Okubo J, Ozaki M, Kanatome A, Ohya R, Miura Y, Obara K, Shibata S.

      October 16, 2026

    16. PMID30097067

      Citrulline malate supplementation does not improve German Volume Training performance or reduce muscle soreness in moderately trained males and females

      October 16, 2026

    17. PMID3115841

      Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis.

      Griffith RS, Walsh DE, Myrmel KH, Thompson RW, Behforooz A.

      October 16, 2026

    18. PMID37289866

      Taurine deficiency as a driver of aging.

      Singh P, Gollapalli K, Mangiola S, Schranner D, Yusuf MA, Chamoli M, Shi SL, Lopes Bastos B, Nair T, Riermeier A, Vayndorf EM, Wu JZ, Nilakhe A, Nguyen CQ, Muir M, Kiflezghi MG, Foulger A, Junker A, Devine J, Sharan K, Chinta SJ, Rajput S, Rane A, Baumert P, Schönfelder M, Iavarone F, di Lorenzo G, Kumari S, Gupta A, Sarkar R, Khyriem C, Chawla AS, Sharma A, Sarper N, Chattopadhyay N, Biswal BK, Settembre C, Nagarajan P, Targoff KL, Picard M, Gupta S, Velagapudi V, Papenfuss AT, Kaya A, Ferreira MG, Kennedy BK, Andersen JK, Lithgow GJ, Ali AM, Mukhopadhyay A, Palotie A, Kastenmüller G, Kaeberlein M, Wackerhage H, Pal B, Yadav VK.

      October 16, 2026

    19. PMID6419679

      Failure of lysine in frequently recurrent herpes simplex infection. Treatment and prophylaxis.

      DiGiovanna JJ, Blank H.

      October 16, 2026

    20. REG-CARNITINE

      DailyMed: Levocarnitine injection

      October 16, 2026

    21. REG-NAC

      DailyMed: Acetylcysteine injection

      October 16, 2026

    22. SEARCH-PUBMED-arginine

      PubMed/MED targeted search: TITLE_ABS:"L-arginine" AND TITLE_ABS:"myocardial infarction" AND TITLE_ABS:randomized

      October 16, 2026

    23. SEARCH-PUBMED-glutamine

      PubMed/MED targeted search: TITLE_ABS:glutamine AND TITLE_ABS:"critically ill" AND TITLE_ABS:randomized

      October 16, 2026

    24. SEARCH-PUBMED-l-carnitine

      PubMed/MED targeted search: TITLE:"L-carnitine" AND TITLE:randomized

      October 16, 2026

    25. SEARCH-PUBMED-lysine

      PubMed/MED targeted search: TITLE_ABS:lysine AND TITLE_ABS:"herpes simplex" AND TITLE_ABS:trial

      October 16, 2026

    26. SEARCH-PUBMED-nac

      PubMed/MED targeted search: TITLE_ABS:acetylcysteine AND TITLE_ABS:acetaminophen AND TITLE_ABS:randomized

      October 16, 2026

    27. SEARCH-PUBMED-ornithine

      PubMed/MED targeted search: TITLE_ABS:"L-ornithine" AND TITLE_ABS:sleep AND TITLE_ABS:randomized

      October 16, 2026

    28. SEARCH-PUBMED-proline

      PubMed/MED targeted search: TITLE_ABS:proline AND TITLE_ABS:supplementation AND TITLE_ABS:human

      October 16, 2026

    A community-based bilingual scientific education initiative for healthcare professionals and the general public across the Americas.Currently self-funded; no current sponsors. Formal governance and legal documentation pending.info@peptideamericas.org · Planned contact address — not active yet; please do not send messages.